The Kasa Smart Plug transformed my home. Save up to 45% on plugs, surge protectors, bulbs
I've always considered myself to be pretty tech-savvy, so I'm honestly not sure how I went so long without trying a smart plug. Everything changed for me on Black Friday 2024, when I finally picked up a Kasa Smart Plug, and I haven't looked back since.
If you're shopping for smart home deals ahead of Amazon Prime Day 2025, let me save you some time: Kasa Smart Plugs are a total game-changer.
I started with a single Kasa Smart Plug to control my Christmas lights. It took took less than three minutes to figure out: I downloaded the Kasa app, added the device, plugged in my lights and instantly started turning them on and off from my phone like a kid with a new toy.
The next day? I was hooked. I ordered the Kasa Smart Wi-Fi Power Strip and a 4-pack of Kasa Mini Smart Plugs.
Outside of the holidays, I use my Kasa plugs to automate almost all of my home lighting. My table and floor lamps are now on a schedule—turning on automatically at sunset and off at bedtime. It is simple, seamless and honestly, kind of magical.
Early Amazon Prime Day deals: Kasa Smart Home
I found several Kasa smart home devices that are discounted by up to 50% at Amazon. Shop my favorite Kasa deals below.
1. Kasa Smart Plug 2-Pack
2. Kasa Smart Plug Mini 15A 4-Pack
Get 20% off: Kasa Smart Plug Ultra Mini 15A
3. Kasa KL125P4 Smart Light Bulb 4-Pack
4. Kasa Smart Plug Power Strip HS300 with 6 Smart Outlets and 3 USB Port
5. Kasa Smart Motion Sensor Switch, Dimmer Light Switch
Get 24% off: Kasa Smart Light Switch HS200P3, 3-Pack
6. Kasa Outdoor Smart Plug with 2 Sockets
7. Kasa 2K QHD Security Camera Pan/Tilt
Get 17% off: Kasa Smart 2K QHD Indoor Security Camera
What are the dates of Amazon Prime Day 2025?
Amazon's 2025 Prime Day sale will run from Tuesday, July 8 through Friday, July 11 this year. It is the first year that the sale will be extended from two days to four.
We'll be monitoring all the best and most unbelievable Amazon deals throughout the sale, so be sure to check out all the top USA TODAY Shopping coverage and sign up for our weekly newsletter to catch even more shopping tips!
🛍️ Follow us on Instagram! Check out USA TODAY Shopping for tips, trends and more
Yes, Prime Day deals are only available to Amazon Prime members. The July Prime Day sale offers incredible Prime member-exclusive discounts on select products that can help members save more than anyone else.
Plus, joining Prime helps guarantee you get other perks like fast shipping all year long!
New members can try one week of Amazon Prime benefits for just $1.99. After that, Prime costs $14.99 per month or $139 per year. The annual plan will save you about $40 total compared to paying monthly.
More: Is an Amazon Prime membership worth it? Here's what you need to know
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Wall Street Journal
30 minutes ago
- Wall Street Journal
A Crucial Moment for Crypto Legislation
The internet of the mid-1990s looked quite different from today. Amazon sold only books, Google didn't exist, and there was no practical way I could use it to help expand the restaurant chain my brothers and I had begun in Pennsylvania. The World Wide Web was an interesting idea, but few fully understood how much it would revolutionize our daily lives. That changed when Congress passed the Telecommunications Act of 1996, the first set of rules and guardrails around the development of the internet. The law enabled telephone and cable companies to offer broadband services. Congress's action opened markets to competition and gave companies the clarity they needed to develop services for new technologies and scale them across the country. By 2014 broadband providers had made $1.4 trillion in capital investments to build the internet's infrastructure. Under clear, light-touch regulation, the internet flourished and America became the tech capital of the world.
Yahoo
an hour ago
- Yahoo
Amazon has 100s of Canada Day deals ahead of Prime Day 2025 — save up to 88% on home, tech, kitchen and more
How are you celebrating the Canada Day long weekend? Between firework displays and backyard (or indoor) cookouts, Canadian have so much to look forward to this long weekend — including shopping hundreds of early Prime Day deals over at Amazon Canada. Shop the best early Amazon Prime Day deals by category below: Tech deals: Shop all tech deals Home deals: Shop all home deals Kitchen deals: Shop all kitchen deals Beauty deals: Shop all beauty deals Fashion deals: Shop all fashion deals Personal care deals: Shop all personal care deals Lawn and garden deals: Shop all lawn and garden deals Ahead of Amazon Prime Day 2025 — it kicks off July 8 and runs through July 11 — you can score big savings on everything from home gadgets and beauty must-haves to bestselling tech and more. Whether you're relaxing by the pool or scrolling while BBQing, these early bargains are worth taking a peek at. We've rounded up the best Canada Day deals to shop now — with discounts of up to 80 per cent and more (seriously!). Not in the Amazon mood? No worries: Lululemon just dropped a ton of new We Made Too Much scores in time for Canada Day Best Buy's Black Friday in Summer sale is on now — save $100s Silk & Snow is having an epic Canada Day sale — save on bedding, bed frames, furniture & moreIn this guide: Early Prime Day home deals | Early Prime Day tech deals | Early Prime Day kitchen deals | Early Prime Day beauty & wellness deals By the way — did we mention that with every Amazon or Prime Video purchase of $20 or more, there's a chance to win huge prizes? Amazon's Giftmania is on through the end of Prime Day, July 11. Click here for all the details.
Business Wire
an hour ago
- Business Wire
Revelation Biosciences Inc. Announces 1-for-3 Reverse Stock Split Effective July 7, 2025
SAN DIEGO--(BUSINESS WIRE)-- Revelation Biosciences, Inc. (NASDAQ: REVB) (the 'Company' or 'Revelation'), announced today that, on July 7, 2025, the Company will implement a 1-for-3 reverse split of its common stock following approval at its Special Meeting of Stockholders held on June 23, 2025. The reverse stock split will be effective as of the morning of July 7, 2025, and the Company's common stock will trade on a post-split basis at the beginning of trading on the same date under the existing trading symbol 'REVB.' The CUSIP number for the common stock following the reverse stock split will be 76135L705. The reverse stock split is intended to increase the market price per share of the Company's common stock to regain compliance with the minimum bid continued listing requirement of The Nasdaq Capital Market. Proportionate adjustments will be made to the conversion and exercise prices of the company's warrants, restricted stock unit awards, stock options and to the number of shares issued and issuable under the Company's equity incentive plans. Separately, the Company also announced that it's ongoing PRIME Phase 1b clinical study of Gemini in CKD patients is expected to complete enrollment this month and topline data expected shortly after. For more information on Revelation, please visit Information for Stockholders Upon the effectiveness of the reverse stock split, each sixteen shares of the Company's issued and outstanding common stock will be automatically combined and converted into one issued and outstanding share of common stock. The reverse stock split will affect all stockholders uniformly and will not alter any stockholder's relative interest in the Company's equity, except to the extent that the reverse stock split would have resulted in a stockholder owning a fractional share. Holders of common stock otherwise entitled to a fractional share as a result of the Reverse Stock Split because they hold a number of shares not evenly divisible by the Reverse Stock Split ratio will be rounded down to the nearest whole share. The reverse stock split will not change the par value of the common stock or modify the rights or preferences of the common stock. The Company's transfer agent, Continental Stock Transfer & Trust Co., will maintain the book-entry records for the Company's common stock. Registered stockholders holding pre-split shares of the Company's common stock electronically in book-entry form are not required to take any action to receive post-split shares. Stockholders owning shares via a broker, bank, trust or other nominee will have their positions automatically adjusted to reflect the reverse stock split, subject to such broker's particular processes, and will not be required to take any action in connect with the reverse stock split. Continental Stock Transfer & Trust Co. can be reached at (212) 509-4000 or (800)-509-5586. About Revelation Biosciences, Inc. Revelation Biosciences, Inc. is a clinical stage life sciences company focused on harnessing the power of trained immunity for the prevention and treatment of disease using its proprietary formulation Gemini. Revelation has multiple ongoing programs to evaluate Gemini, including as a prevention for post-surgical infection, as a prevention for acute kidney injury, and for the treatment of chronic kidney disease. For more information on Revelation, please visit Forward-Looking Statements This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These forward-looking statements are generally identified by the words "anticipate", "believe", "expect", "estimate", "plan", "outlook", and "project" and other similar expressions. We caution investors that forward-looking statements are based on management's expectations and are only predictions or statements of current expectations and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from those anticipated by the forward-looking statements. Revelation cautions readers not to place undue reliance on any such forward looking statements, which speak only as of the date they were made. The following factors, among others, could cause actual results to differ materially from those described in these forward-looking statements: the ability of Revelation to meet its financial and strategic goals, due to, among other things, competition; the ability of Revelation to grow and manage growth profitability and retain its key employees; the possibility that the Revelation may be adversely affected by other economic, business, and/or competitive factors; risks relating to the successful development of Revelation's product candidates; the ability to successfully complete planned clinical studies of its product candidates; the risk that we may not fully enroll our clinical studies or enrollment will take longer than expected; risks relating to the occurrence of adverse safety events and/or unexpected concerns that may arise from data or analysis from our clinical studies; changes in applicable laws or regulations; expected initiation of the clinical studies, the timing of clinical data; the outcome of the clinical data, including whether the results of such study is positive or whether it can be replicated; the outcome of data collected, including whether the results of such data and/or correlation can be replicated; the timing, costs, conduct and outcome of our other clinical studies; the anticipated treatment of future clinical data by the FDA, the EMA or other regulatory authorities, including whether such data will be sufficient for approval; the success of future development activities for its product candidates; potential indications for which product candidates may be developed; the ability of Revelation to maintain the listing of its securities on NASDAQ; the expected duration over which Revelation's balances will fund its operations; and other risks and uncertainties described herein, as well as those risks and uncertainties discussed from time to time in other reports and other public filings with the SEC by Revelation.
